Novavax reports progress on RSV vaccine

theflyonthewall.com

Novavax reported that RSV vaccine candidate induced anti-RSV antibodies capable of neutralizing RSV in vitro and significantly reduced infectious RSV in a cotton rat challenge model. Further, in both clinical and preclinical studies, the company reported that palivizumab-competing antibodies were generated at titers significantly above that found to be protective in both humans and cottons rats.

View Comments (0)